The pharmaceutical industry faces a unique double mandate: safeguard patient health while simultaneously addressing its environmental responsibilities. At Bioaltus Pharmaceuticals Pvt. Ltd., we believe these goals are complementary rather than conflicting. Over the past few years, we have invested significantly in sustainable packaging innovation, integrating eco-conscious practices throughout our production pipeline to reduce waste, lower carbon emissions, and help our partners meet increasingly stringent global sustainability standards without compromising product integrity or safety.
Our commitment begins with material selection. Wherever regulatory guidelines permit, Bioaltus has transitioned from conventional virgin plastics to recyclable polymers, pharmaceutical-grade recycled PET, and low-density eco-friendly laminates. For solid-dosage blister packs, we have adopted high-barrier, PVC-free films that maintain moisture protection while reducing chlorinated plastic waste. In liquid formulations, we now provide lightweight HDPE bottles with reduced resin content, cutting plastic usage by up to 18 percent per unit. These material choices are carefully validated in our stability chambers to guarantee that shelf life, active-ingredient potency, and patient safety remain intact.
Beyond material changes, we have re-engineered our packaging formats to minimize excess volume. By utilizing precision blister-cavity design, nesting vial trays, and compact secondary cartons, we reduce each package’s physical footprint, enabling more units per shipping pallet. This translates directly into fewer transport runs and a measurable reduction in Scope 3 carbon emissions for our partners. Simultaneously, optimized carton structures lower the consumption of paperboard sourced from sustainably managed forests, aligning our operations with global forestry stewardship benchmarks.
A critical aspect of sustainable packaging is manufacturing efficiency. Bioaltus has upgraded its primary and secondary packaging lines with servo-controlled, energy-efficient machinery that consumes less electricity per unit packaged. We have integrated in-line vision inspection to catch inconsistencies early, significantly reducing batch reworks and packaging scrap. Any inevitable off-cuts—plastic trims, aluminum foil remnants, or board edge trimmings—are segregated at the source and sent to certified recyclers, ensuring that waste streams are responsibly managed.
Our sustainability efforts extend to labeling and inks. We employ soy-based and water-based inks that deliver the same print legibility and durability as solvent-based alternatives while releasing fewer volatile organic compounds. Wherever feasible, we combine multi-language information into a single, fold-out leaflet or digitally printed QR-code insert, reducing paper usage and giving end users easy access to expanded, up-to-date product information online.
For clients exporting to regions with mandatory Extended Producer Responsibility (EPR) regulations—such as the European Union—we provide full transparency on material composition, recyclability indices, and carbon-reduction metrics. Our regulatory and sustainability teams collaborate with partners to generate the documentation needed for green-compliance submissions, helping them secure market access and bolster their brand reputation as environmentally responsible healthcare providers.
Innovation at Bioaltus is an ongoing process. We are currently piloting bio-based blister films derived from renewable feedstocks and exploring smart “digital label” solutions that could eventually replace paper inserts altogether. By pairing these R&D initiatives with continuous lifecycle analyses, we ensure that every sustainability improvement is rooted in verifiable data rather than marketing rhetoric.
Ultimately, sustainable packaging at Bioaltus is not a standalone initiative—it is a core pillar of our broader environmental, social, and governance (ESG) strategy. By embracing circular-economy principles, optimizing material usage, and maintaining uncompromising quality controls, we offer our pharmaceutical partners a manufacturing framework that supports both their commercial objectives and their sustainability commitments.
For healthcare brands determined to reduce their environmental footprint while delivering safe, effective therapies, Bioaltus Pharmaceuticals provides more than manufacturing capacity; we deliver a pathway toward a greener future in pharma one package at a time
Reg. Off: # 25,26,27,28, First Floor,TL-5 Morning Glory Commercial Premises Ltd, Tropical Lagoon, Kavesar, GB Road, Thane(W), Mumbai, Maharashtra-400615, India
19-20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173 205.
Plot No.- 637/P/1/2, Sarigam – Punat road, Post – Angam village, Taluka – Umargam, Dist – Valsad State – Gujarat-396155, India.